Carregant...

Advances in targeted therapy for malignant lymphoma

The incidence of lymphoma has gradually increased over previous decades, and it ranks among the ten most prevalent cancers worldwide. With the development of targeted therapeutic strategies, though a subset of lymphoma patients has become curable, the treatment of refractory and relapsed diseases re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Signal Transduct Target Ther
Autors principals: Wang, Li, Qin, Wei, Huo, Yu-Jia, Li, Xiao, Shi, Qing, Rasko, John E. J., Janin, Anne, Zhao, Wei-Li
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7058622/
https://ncbi.nlm.nih.gov/pubmed/32296035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41392-020-0113-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!